Product Code: GDHC5157CTIDB
GlobalData's clinical trial report, "Alopecia Global Clinical Trials Review, H2, 2019" provides an overview of Alopecia clinical trials scenario. This report provides top line data relating to the clinical trials on AlopeciaReport includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
- List of Tables 4
- List of Figures 5
- Report Guidance 6
- GlobalData Clinical Trials Report Coverage 7
- Clinical Trials by Region 8
- Clinical Trials and Average Enrollment by Country 10
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific 13
- Top Five Countries Contributing to Clinical Trials in Europe 14
- Top Countries Contributing to Clinical Trials in North America 15
- Top Five Countries Contributing to Clinical Trials in Middle East and Africa 16
- Top Five Countries Contributing to Clinical Trials in Central and South America 17
- Clinical Trials by G7 Countries: Proportion of Alopecia to Dermatology Clinical Trials 18
- Clinical Trials by Phase in G7 Countries 19
- Clinical Trials in G7 Countries by Trial Status 20
- Clinical Trials by E7 Countries: Proportion of Alopecia to Dermatology Clinical Trials 21
- Clinical Trials by Phase in E7 Countries 22
- Clinical Trials in E7 Countries by Trial Status 23
- Clinical Trials by Phase 25
- In Progress Trials by Phase 26
- Clinical Trials by Trial Status 27
- Clinical Trials by End Point Status 29
- Subjects Recruited Over a Period of Time 30
- Clinical Trials by Sponsor Type 31
- Prominent Sponsors 32
- Top Companies Participating in Alopecia Therapeutics Clinical Trials 34
- Prominent Drugs 35
- Latest Clinical Trials News on Alopecia 36
- Nov 13, 2019: Cassiopea announces first patient to be enrolled in phase II trial for the treatment of androgenetic alopecia in females with Clascoterone solution 36
- Oct 21, 2019: Follicum successfully completes toxicology studies for upcoming FOL-005 Phase IIa clinical trial in patients with hair loss 36
- Clinical Trial Profile Snapshots 38
Appendix 269
- Abbreviations 269
- Definitions 269
- Research Methodology 270
- Secondary Research 270
- About GlobalData 271
- Contact Us 271
- Source 272
比較リスト
